Robbins LLP Reminds Brainstorm Cell Therapeutics Inc. Investors of Upcoming Lead Plaintiff Deadline in Class Action Against BCLI

<p>SAN DIEGO, Dec. 15, 2023 (GLOBE NEWSWIRE) &#8212; Robbins LLP reminds investors that a shareholder filed a class action lawsuit on behalf of persons and entities that purchased or otherwise acquired Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) securities between August 15, 2022 and September 27, 2023. Brainstorm Cell is a biotechnology company that develops and commercializes [&#8230;]</p>
<p>The post <a href="https://forextv.com/top-news/robbins-llp-reminds-brainstorm-cell-therapeutics-inc-investors-of-upcoming-lead-plaintiff-deadline-in-class-action-against-bcli/">Robbins LLP Reminds Brainstorm Cell Therapeutics Inc. Investors of Upcoming Lead Plaintiff Deadline in Class Action Against BCLI</a> appeared first on <a href="https://forextv.com">ForexTV</a>.</p>